Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    Menu

    Oxcarbamazepine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 172Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Steranco’s Generics Oxcarbazepine Receives Approval in US
    Steranco’s Generics Oxcarbazepine Receives Approval in US

    09 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220281

    FDA
    09 Mar 2026
    Share Share
    Epic Pharma’s Generics Oxcarbazepine Receives Approval in US
    Epic Pharma’s Generics Oxcarbazepine Receives Approval in US

    02 Mar 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219556

    FDA
    02 Mar 2026
    Share Share
    Lupin Gets Tentative US FDA Nod for Oxcarbazepine Tablet
    Lupin Gets Tentative US FDA Nod for Oxcarbazepine Tablet

    09 Jun 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/lupin-receives-tentative-us-fda-approval-for-oxcarbazepine-er-tablets/

    EXPRESSPHARMA
    09 Jun 2025
    Share Share
    Bicon`s Generics Oxcarbazepine Receives Tentative Approval in US
    Bicon`s Generics Oxcarbazepine Receives Tentative Approval in US

    08 Jan 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218442

    FDA
    08 Jan 2025
    Share Share
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.
    Ajanta Pharma`s Generic Oxcarbazepine Receives Approval in the U.S.

    23 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217659

    FDA
    23 Feb 2024
    Share Share
    Medley Pharma's Generic Oxcarbazepine Receives Approval in the U.S.
    Medley Pharma's Generic Oxcarbazepine Receives Approval in the U.S.

    14 Feb 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217782

    FDA
    14 Feb 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.